BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Petry NM, Alessi SM, Olmstead TA, Rash CJ, Zajac K. Contingency management treatment for substance use disorders: How far has it come, and where does it need to go? Psychol Addict Behav 2017;31:897-906. [PMID: 28639812 DOI: 10.1037/adb0000287] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Derefinko KJ, Salgado García FI, Sumrok DD. Smoking Cessation for Those Pursuing Recovery from Substance Use Disorders. Medical Clinics of North America 2018;102:781-96. [DOI: 10.1016/j.mcna.2018.02.014] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
2 Becker SJ, Murphy CM, Hartzler B, Rash CJ, Janssen T, Roosa M, Madden LM, Garner BR. Project MIMIC (Maximizing Implementation of Motivational Incentives in Clinics): A cluster-randomized type 3 hybrid effectiveness-implementation trial. Addict Sci Clin Pract 2021;16:61. [PMID: 34635178 DOI: 10.1186/s13722-021-00268-0] [Reference Citation Analysis]
3 Gustafson Sr D, Horst J, Boss D, Fleddermann K, Jacobson N, Roosa M, Ross J, Gicquelais R, Vjorn O, Siegler T, Molfenter T. What helps implement smartphone systems designed to improve quality of life for people with substance use disorder: an interim report on a randomized controlled trial with SUD providers in Iowa (Preprint). JMIR Human Factors. [DOI: 10.2196/35125] [Reference Citation Analysis]
4 Humphreys K, Kilmer B. Still HOPEful: Reconsidering a "failed" replication of a swift, certain, and fair approach to reducing substance use among individuals under criminal justice supervision. Addiction 2020;115:1973-7. [PMID: 32281705 DOI: 10.1111/add.15049] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
5 Scholes G. Problematic alcohol consumption in homeless Australians: A narrative review of the causes, barriers to receiving help and possible solutions. Health Promot J Austr 2020;31:279-86. [PMID: 31446632 DOI: 10.1002/hpja.289] [Reference Citation Analysis]
6 Destoop M, Docx L, Morrens M, Dom G. Meta-Analysis on the Effect of Contingency Management for Patients with Both Psychotic Disorders and Substance Use Disorders. J Clin Med 2021;10:616. [PMID: 33561966 DOI: 10.3390/jcm10040616] [Reference Citation Analysis]
7 Connery HS, McHugh RK, Reilly M, Shin S, Greenfield SF. Substance Use Disorders in Global Mental Health Delivery: Epidemiology, Treatment Gap, and Implementation of Evidence-Based Treatments. Harv Rev Psychiatry 2020;28:316-27. [PMID: 32925514 DOI: 10.1097/HRP.0000000000000271] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
8 Lin LA, Bohnert ASB, Blow FC, Gordon AJ, Ignacio RV, Kim HM, Ilgen MA. Polysubstance use and association with opioid use disorder treatment in the US Veterans Health Administration. Addiction 2021;116:96-104. [PMID: 32428386 DOI: 10.1111/add.15116] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 23.0] [Reference Citation Analysis]
9 Pfund RA, Cook JE, McAfee NW, Huskinson SL, Parker JD. Challenges to Conducting Contingency Management Treatment for Substance Use Disorders: Practice Recommendations for Clinicians. Prof Psychol Res Pr 2021;52:137-45. [PMID: 34421192 DOI: 10.1037/pro0000356] [Reference Citation Analysis]
10 Johnson S, Rains LS, Marwaha S, Strang J, Craig T, Weaver T, McCrone P, King M, Fowler D, Pilling S, Marston L, Omar RZ, Craig M, Spencer J, Hinton M. A contingency management intervention to reduce cannabis use and time to relapse in early psychosis: the CIRCLE RCT. Health Technol Assess 2019;23:1-108. [PMID: 31460865 DOI: 10.3310/hta23450] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
11 Del Palacio-Gonzalez A, Hesse M, Thylstrup B, Pedersen MU, Pedersen MM. Effects of contingency management and use of reminders for drug use treatment on readmission and criminality among young people: A linkage study of a randomized trial. J Subst Abuse Treat 2021;:108617. [PMID: 34544626 DOI: 10.1016/j.jsat.2021.108617] [Reference Citation Analysis]
12 Desrosiers JJ, Tchiloemba B, Boyadjieva R, Jutras-Aswad D. Implementation of a contingency approach for people with co-occurring substance use and psychiatric disorders: Acceptability and feasibility pilot study. Addict Behav Rep 2019;10:100223. [PMID: 31828202 DOI: 10.1016/j.abrep.2019.100223] [Reference Citation Analysis]
13 Zastepa E, Sun JC, Clune J, Mathew N. Adaptation of contingency management for stimulant use disorder during the COVID-19 pandemic. J Subst Abuse Treat 2020;118:108102. [PMID: 32854983 DOI: 10.1016/j.jsat.2020.108102] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Raiff BR, Burrows C, Dwyer M. Behavior-Analytic Approaches to the Management of Diabetes Mellitus: Current Status and Future Directions. Behav Anal Pract 2021;14:240-52. [PMID: 33732594 DOI: 10.1007/s40617-020-00488-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 González-Roz A, Weidberg S, García-Pérez Á, Martínez-Loredo V, Secades-Villa R. One-Year Efficacy and Incremental Cost-effectiveness of Contingency Management for Cigarette Smokers With Depression. Nicotine Tob Res 2021;23:320-6. [PMID: 32772097 DOI: 10.1093/ntr/ntaa146] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
16 Lent MR, Callahan HR, Womer P, Mullen PM, Shook CB, DiTomasso RA, Felgoise SH, Festinger DS. A mental health professional survey of cognitive-behavioral therapy for the treatment of opioid use disorder. J Clin Psychol 2021;77:1607-13. [PMID: 33971028 DOI: 10.1002/jclp.23170] [Reference Citation Analysis]
17 Sheridan Rains L, Steare T, Mason O, Johnson S. Improving substance misuse outcomes in contingency management treatment with adjunctive formal psychotherapy: a systematic review and meta-analysis. BMJ Open 2020;10:e034735. [PMID: 33033080 DOI: 10.1136/bmjopen-2019-034735] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Proctor SL. Rewarding recovery: the time is now for contingency management for opioid use disorder. Ann Med 2022;54:1178-87. [PMID: 35471190 DOI: 10.1080/07853890.2022.2068805] [Reference Citation Analysis]
19 Lim TV, Cardinal RN, Bullmore ET, Robbins TW, Ersche KD. Impaired learning from negative feedback in stimulant use disorder: Dopaminergic modulation. Int J Neuropsychopharmacol 2021:pyab041. [PMID: 34197589 DOI: 10.1093/ijnp/pyab041] [Reference Citation Analysis]
20 Burdman F. A pluralistic account of degrees of control in addiction. Philos Stud 2022;179:197-221. [DOI: 10.1007/s11098-021-01656-7] [Reference Citation Analysis]
21 Pfund RA, Ginley MK, Rash CJ, Zajac K. Contingency management for treatment attendance: A meta-analysis. J Subst Abuse Treat 2021;:108556. [PMID: 34210566 DOI: 10.1016/j.jsat.2021.108556] [Reference Citation Analysis]
22 Kim HS, Hodgins DC. Component Model of Addiction Treatment: A Pragmatic Transdiagnostic Treatment Model of Behavioral and Substance Addictions. Front Psychiatry 2018;9:406. [PMID: 30233427 DOI: 10.3389/fpsyt.2018.00406] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 7.3] [Reference Citation Analysis]
23 Petry NM, Alessi SM, Rash CJ, Barry D, Carroll KM. A randomized trial of contingency management reinforcing attendance at treatment: Do duration and timing of reinforcement matter? J Consult Clin Psychol 2018;86:799-809. [PMID: 30265039 DOI: 10.1037/ccp0000330] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
24 Gagnon M, Guta A, Payne A. "Setting people up for success and then failure" - health care and service providers' experiences of using prize-based contingency management. Subst Abuse Treat Prev Policy 2020;15:71. [PMID: 32928275 DOI: 10.1186/s13011-020-00316-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
25 Rash CJ, DePhilippis D. Considerations for Implementing Contingency Management in Substance Abuse Treatment Clinics: The Veterans Affairs Initiative as a Model. Perspect Behav Sci 2019;42:479-99. [PMID: 31976446 DOI: 10.1007/s40614-019-00204-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
26 Wagner JA, Petry NM, Weyman K, Tichy E, Cengiz E, Zajac K, Tamborlane WV. Glucose management for rewards: A randomized trial to improve glucose monitoring and associated self-management behaviors in adolescents with type 1 diabetes. Pediatr Diabetes 2019;20:997-1006. [PMID: 31271239 DOI: 10.1111/pedi.12889] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
27 Traynor SM, Metsch LR, Gooden L, Stitzer M, Matheson T, Tross S, Carrico AW, Jain MK, Del Rio C, Feaster DJ. Self-efficacy as a mediator of patient navigation interventions to engage persons living with HIV and substance use. Drug Alcohol Depend 2021;221:108567. [PMID: 33610093 DOI: 10.1016/j.drugalcdep.2021.108567] [Reference Citation Analysis]
28 Acuff SF, Dennhardt AA, Correia CJ, Murphy JG. Measurement of substance-free reinforcement in addiction: A systematic review. Clin Psychol Rev 2019;70:79-90. [PMID: 30991244 DOI: 10.1016/j.cpr.2019.04.003] [Cited by in Crossref: 15] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
29 Kariisa M, Seth P, Scholl L, Wilson N, Davis NL. Drug overdose deaths involving cocaine and psychostimulants with abuse potential among racial and ethnic groups - United States, 2004-2019. Drug Alcohol Depend 2021;227:109001. [PMID: 34492555 DOI: 10.1016/j.drugalcdep.2021.109001] [Reference Citation Analysis]
30 Wang W, Gellings Lowe N, Jalali A, Murphy SM. Economic modeling of reSET-O, a prescription digital therapeutic for patients with opioid use disorder. J Med Econ 2021;24:61-8. [PMID: 33267633 DOI: 10.1080/13696998.2020.1858581] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
31 Goldenberg M D.O, Miotto K M.D, Skipper GE M.D, Sanford J B.A. Outcomes of Physicians with Substance Use Disorders in State Physician Health Programs: A Narrative Review. J Psychoactive Drugs 2020;52:195-202. [PMID: 32156222 DOI: 10.1080/02791072.2020.1734696] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 DePhilippis D, Petry NM, Bonn-Miller MO, Rosenbach SB, McKay JR. The national implementation of Contingency Management (CM) in the Department of Veterans Affairs: Attendance at CM sessions and substance use outcomes. Drug Alcohol Depend 2018;185:367-73. [PMID: 29524874 DOI: 10.1016/j.drugalcdep.2017.12.020] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 5.5] [Reference Citation Analysis]
33 Gagnon M, Payne A, Guta A. What are the ethical implications of using prize-based contingency management in substance use? A scoping review. Harm Reduct J 2021;18:82. [PMID: 34348710 DOI: 10.1186/s12954-021-00529-w] [Reference Citation Analysis]
34 Kuijper FM, Mahajan UV, Ku S, Barbosa DAN, Alessi SM, Stein SC, Kampman KM, Bentzley BS, Halpern CH. Deep Brain Stimulation Compared With Contingency Management for the Treatment of Cocaine Use Disorders: A Threshold and Cost-Effectiveness Analysis. Neuromodulation 2021. [PMID: 34028131 DOI: 10.1111/ner.13410] [Reference Citation Analysis]
35 Boucher EM, Ward HE, Mounts AC, Parks AC. Engagement in Digital Mental Health Interventions: Can Monetary Incentives Help? Front Psychol 2021;12:746324. [PMID: 34867629 DOI: 10.3389/fpsyg.2021.746324] [Reference Citation Analysis]
36 Yen Li M, Alba GA, Mitton J, Bearnot B. Care-engaged individuals with polysubstance use in Northeastern US are undertreated for methamphetamine use disorder: a retrospective cohort study. Addict Sci Clin Pract 2021;16:57. [PMID: 34565489 DOI: 10.1186/s13722-021-00267-1] [Reference Citation Analysis]
37 Kawasaki S, Francis E, Mills S, Buchberger G, Hogentogler R, Kraschnewski J. Multi-model implementation of evidence-based care in the treatment of opioid use disorder in Pennsylvania. J Subst Abuse Treat 2019;106:58-64. [PMID: 31540612 DOI: 10.1016/j.jsat.2019.08.016] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 5.7] [Reference Citation Analysis]
38 Shishani K, Odom-Maryon T, Roll JM. A randomized clinical trial to evaluate the efficacy of contingency management for treatment of waterpipe tobacco addiction. Am J Addict 2018;27:202-9. [PMID: 29569328 DOI: 10.1111/ajad.12708] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
39 Dorey L, Christensen DR, May R, Hoon AE, Dymond S. Gambling treatment service providers' views about contingency management: a thematic analysis. Harm Reduct J 2022;19:19. [PMID: 35216604 DOI: 10.1186/s12954-022-00600-0] [Reference Citation Analysis]
40 Rash CJ, Alessi SM, Zajac K. Examining implementation of contingency management in real-world settings. Psychol Addict Behav 2020;34:89-98. [PMID: 31343197 DOI: 10.1037/adb0000496] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
41 Ginley MK, Pfund RA, Rash CJ, Zajac K. Long-term efficacy of contingency management treatment based on objective indicators of abstinence from illicit substance use up to 1 year following treatment: A meta-analysis. J Consult Clin Psychol 2021;89:58-71. [PMID: 33507776 DOI: 10.1037/ccp0000552] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
42 Wilson SM, Newins AR, Medenblik AM, Kimbrel NA, Dedert EA, Hicks TA, Neal LC, Beckham JC, Calhoun PS. Contingency Management Versus Psychotherapy for Prenatal Smoking Cessation: A Meta-Analysis of Randomized Controlled Trials. Womens Health Issues 2018;28:514-23. [PMID: 30061033 DOI: 10.1016/j.whi.2018.05.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]